These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6484432)

  • 41. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
    Delitala G; Alagna S; Masala A
    Clin Ter; 1977 Jun; 81(6):547-54. PubMed ID: 884939
    [No Abstract]   [Full Text] [Related]  

  • 42. [Results in the treatment of obesity by Mazindol (AN 448 Sandoz) in hospitalized subjects using the method of double-blind trial (author's transl)].
    Kreze A; Velemínsky J; Toman A
    Bratisl Lek Listy; 1976 May; 65(5):537-43. PubMed ID: 788862
    [No Abstract]   [Full Text] [Related]  

  • 43. [Evaluation of the effect of mazindol on the metabolism and lipolysis in obese women].
    Kucio C; Zahorska-Markiewicz B; Piskorska D; Semenowicz-Siuda K; Waluga M
    Pol Arch Med Wewn; 1987 Mar; 77(3):73-6. PubMed ID: 3275392
    [No Abstract]   [Full Text] [Related]  

  • 44. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
    Gołebiowska M; Chlebna-Sokoł D; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(2):311-4. PubMed ID: 7017826
    [No Abstract]   [Full Text] [Related]  

  • 45. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
    [No Abstract]   [Full Text] [Related]  

  • 47. Selegiline in narcolepsy.
    Roselaar SE; Langdon N; Lock CB; Jenner P; Parkes JD
    Sleep; 1987 Oct; 10(5):491-5. PubMed ID: 3120270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multi-centre trial of mazindol ('Teronac') in general practice in Ireland.
    Evans ER; Wallace MG
    Curr Med Res Opin; 1975; 3(3):132-7. PubMed ID: 1149481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Teronac in the treatment of obesity].
    Zahorska-Markiewicz B
    Pol Tyg Lek; 1976 Jun; 31(25):1085-7. PubMed ID: 781638
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
    Sanders M; Breidahl H
    Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of obesity using a new anorectic].
    Felt V
    Vnitr Lek; 1976 Apr; 22(4):371-4. PubMed ID: 1266099
    [No Abstract]   [Full Text] [Related]  

  • 52. [Drug therapy in obesity].
    Ishii J
    Nihon Rinsho; 1988 Nov; 46(11):2491-6. PubMed ID: 3241376
    [No Abstract]   [Full Text] [Related]  

  • 53. Slowed gastric evacuation accounts for the reduction of food intake by anorectic drugs.
    Jonderko K; Kucio C; Skrzypek D
    Eur J Clin Nutr; 1988 Jul; 42(7):627-31. PubMed ID: 3066620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Letter: Drugs in obesity.
    Jackson WP; Vinik AI
    S Afr Med J; 1975 May; 49(20):803. PubMed ID: 1098170
    [No Abstract]   [Full Text] [Related]  

  • 55. Maziniol in the treatment of obesity.
    Sedgwick JP
    Practitioner; 1975 Mar; 214(1281):418-20. PubMed ID: 1096123
    [No Abstract]   [Full Text] [Related]  

  • 56. [Anorexiant drugs in the ambulant treatment of obese patients (author's transl)].
    Jenny S; Zimmermann KG; Radielovic P; Bühlmann AA
    Schweiz Rundsch Med Prax; 1976 Jul; 65(28):874-8. PubMed ID: 1005298
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of a growth hormone inhibitor on the course of Duchenne's myopathy].
    Serratrice G; Desnuelle C
    Presse Med; 1988 Nov; 17(41):2201. PubMed ID: 2974583
    [No Abstract]   [Full Text] [Related]  

  • 58. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM; Howard AN
    Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)].
    Mies R
    Med Klin; 1976 Nov; 71(46):2013-6. PubMed ID: 995040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nocturnal rhythm of growth hormone in Duchenne patients: effect of different doses of mazindol and/or cyproheptadine.
    Zatz M; Rapaport D; Pavanello RC; Rocha JM; Vainzof M; Nicolau W
    Am J Med Genet; 1989 Aug; 33(4):457-67. PubMed ID: 2596504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.